Lupin Launches Formoterol Fumarate Inhalation Solution in the US

Global pharma major Lupin Limited (Lupin) today announced the launch of Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial, to market a generic equivalent of Perforomist® Inhalation Solution, 20 mcg/2 mL, of Mylan Specialty, L.P. Formoterol Fumarate Inhalation Solution (RLD Perforomist®) had estimated annual sales of USD 268 million in the U.S. (IQVIA MAT September 2022).

GMM Pfaudler US forms JV with JDS Manufacturing

GMM Pfaudler Ltd's wholly owned subsidiary namely GMM Pfaudler US, USA has incorporated a joint venture company with JDS Manufacturing Inc in USA named "GMM Pfaudler JDS LLC" and has completed the acquisition of 51% shareholding of GMM Pfaudler JDS LLC on November 28, 2022. The joint venture will help both the parties to further develop the high-margin service business and is expected to strengthen GMM Pfaudler Ltd's market position in the USA.